25 results
8-K
EX-99.1
VINC
Vincerx Pharma Inc
14 Nov 23
Vincerx Pharma Reports Third Quarter 2023 Financial Results
12:00am
Society for Hematology Meeting (ASH 2023) in December.
We expect to report preliminary clinical trial data in mid-2024.
VIP236: SMDC with αvb3
8-K
EX-99.1
VINC
Vincerx Pharma Inc
11 May 23
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:02pm
. In preclinical data presented at the American Society of Hematology (ASH) Annual Meeting in 2022, our next-generation kinesin spindle protein inhibitor (KSPi
8-K
EX-99.1
VINC
Vincerx Pharma Inc
10 Nov 22
Vincerx Pharma Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
4:27pm
and 1H2024, respectively
Upcoming poster presentations at the 64th American Society of Hematology (ASH) Annual Meeting in December 2022
Poster titled
8-K
EX-99.1
VINC
Vincerx Pharma Inc
29 Mar 22
Vincerx Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
8:06am
) and CLL at the 63rd American Society of Hematology Annual Meeting 2021
Completed GLP toxicity studies of VIP236 in rats; initiating additional GLP
8-K
EX-99.1
38jcsh1a4id y6s
12 Nov 21
Vincerx Pharma Reports Third Quarter 2021 Financial Results and Provides a
6:16am
424B3
p692ltybwfyj733s
26 Oct 21
Prospectus supplement
8:39am
8-K
EX-99.1
aueof0ru7uuoyxob
12 Aug 21
Vincerx Pharma Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
4:19pm
8-K
EX-99.1
90irorniyx7bml9v
17 May 21
Vincerx Pharma Reports First Quarter 2021 Financial Results
4:02pm
424B3
trc1wyl
10 Feb 21
Prospectus supplement
4:03pm
DEFM14A
975dswb268d swc
4 Dec 20
Proxy related to merger
8:48pm
PRER14A
d4jqyjz 5uo7cetkfn
10 Nov 20
Preliminary revised proxy
4:58pm
PREM14A
1mlqqucnw1 9h3
8 Oct 20
Preliminary proxy related to merger
5:01pm
8-K
EX-99.2
f1ea4 73c915v5w
29 Sep 20
LifeSci Acquisition Corp. Announces Merger
8:32am
DEFA14A
EX-99.2
1geacl1gy4 qeenb7ypw
29 Sep 20
Additional proxy soliciting materials
8:30am
10-K
w1f9hgg
23 Sep 20
Annual report
3:07pm
424B4
l5rku oqietgr
9 Mar 20
Prospectus supplement with pricing info
4:39pm